Pharmaceutical Technology

NOVEMBER 14, 2022

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorisation for Oncopeptides’ Pepaxti (melphalan flufenamide; melflufen) along with dexamethasone to treat multiple myeloma patients. Currently, the company is analysing Pepaxti’s market access options in the country.

Marketing 130

Marketing Drugs Clinical Trials Clinical Trials 130

Intouch Solutions

APRIL 15, 2024

EVERSANA INTOUCH Healthware joins five full-service affiliates and four specialty affiliates serving clients across the globe with world-class strategy, next-generation branding and creative, and innovative solutions to propel the future of life science marketing. They are, however, fully owned and operated by EVERSANA.

Life Science 52

Life Science Branding Marketing Production 52

World of DTC Marketing

NOVEMBER 22, 2021

In the words of the company’s mission , its goal is to “make high-quality health and pharmacy services safe, affordable and easy to access.” Healthcare is ripe for disruption, and CVS could be blazing new trails. health care market, now valued at $3 trillion (the most expensive in the world), needs a new approach.

Pharmacy 241

Pharmacy Nurses Doctors Doctor 241

Camargo

SEPTEMBER 8, 2021

Each month, Camargo’s “In the News” series highlights important changes and advancements in the regulatory and development space and explores how those changes could impact your program. In the News: August 2021 Regulatory and Development Updates. In the News: July 2021 Regulatory and Development Updates.

Development 186

Development Regulation Production Drugs 186

Pharma in Brief

MARCH 27, 2023

billion over three years to help increase drug access and affordability. This funding is intended to improve access to new and emerging drugs for rare diseases and to support enhanced access to existing drugs, screening, and early diagnosis. Links: March 22, 2023 News Release and Health Canada Backgrounder

Drugs 52

Drugs Marketing Clinical Trials Clinical Trials 52

Intouch Solutions

FEBRUARY 8, 2023

Chief Innovation Officer, Faruk Capan, was recently quoted in an Endpoints News article, ChatGPT and generative AI land in pharma marketing with sense of awe — and plenty of caution. Check out the summary below, or access the full article to read the content in its entirety.

Marketing 52

Marketing Production 52

XTalks

JULY 21, 2023

These members now have access to the advanced Iris platform, offering specialized mental health care tailored for oncology patients, 24×7 symptom management and essential nutritional support. That’s where Iris comes in,” said Andrew Norden, chief medical officer at OncoHealth, in the company’s news release. “We RELATED: care.ai

Nurses 98

Nurses Doctors Doctor Clinical Trials 98

Pharmaceutical Technology

SEPTEMBER 2, 2022

Multiple myeloma (MM) therapeutics comprise a multi-billion dollar market, among the most valuable in oncology. Last month, the European Medicines Agency's (EMA) approval of Johnson & Johnson’s (J&J) anti-CD3/BCMA bispecific antibody Tecvayli (teclistamab) marked the fourth anti-BCMA biologic to enter the R/R MM market.

Antibody 147

Antibody Sales FDA Approval Production 147

Drug Discovery World

APRIL 11, 2024

News that the UK is supporting two new initiatives to help further the development of antimicrobials alongside other solutions to tackle resistant infections is welcome news for a sector that has, in recent years, struggled to attract the funding and attention it deserves.

Bacteria 52

Bacteria Life Science Development Containment 52

XTalks

JULY 7, 2023

Moreover, the study identified several distinguishing characteristics of POHs compared to private non-POHs in the same market. POHs were smaller in size, exhibited higher profitability, were more likely to be for-profit, non-teaching, non-critical access and located in metropolitan areas.

Regulation 98

Regulation Marketing Licensing Licensing 98

Drug Discovery World

NOVEMBER 22, 2022

In March 2022, Great Britain was the first country outside of the US to grant a conditional marketing authorisation to mobocertinib, a first-in-class, oral tyrosine kinase inhibitor (TKI) specifically designed to target EGFR Exon 20 insertion mutations. link] Accessed: November 2022. link] Accessed: November 2022. NHS England.

Marketing 52

Marketing Medicine Drugs Production 52

XTalks

JULY 24, 2023

Many third-party supply chain solutions exist in the market, but none have the full suite offerings available in Surgence,” said Cody Fisher, Concordance EVP and strategic advisor in the company’s news release. For patients, it holds utmost importance as it guarantees access to essential medicines and treatments when needed.

Clinical Supply Chain 97

Clinical Supply Chain Clinical Supply Production Marketing 97

pharmaphorum

AUGUST 21, 2020

New insights into smell and taste loss symptoms, artificial intelligence and further encouraging data from a vaccine candidate hit the headlines this week as the COVID-19 coronavirus pandemic continues. Here we highlight the biggest R&D, market access and digital coronavirus news of the past week.

Vaccination 105

Vaccination Vaccine Regulation Manufacturing 105

Camargo

DECEMBER 9, 2020

The August edition of In the News discussed recent FDA guidance detailing the approach to inspections during the COVID-19 pandemic, including the proposed use of various “remote” inspection methods—such as document review—to allow inspections to progress without physical access to the facilities involved.

Development 140

Development Production Drugs FDA Approval 140

Drug Discovery World

JUNE 23, 2023

News round-up for 19-23 June by DDW Digital Content Editor Diana Spencer. Advanced Therapy Medicinal Products (ATMPs) have been making the news this week.

Gene Therapy 52

Gene Therapy Drugs Gene FDA Approval 52

XTalks

JULY 18, 2023

The initiative not only simplifies the member experience by eliminating the need for extensive price comparisons but also ensures accessibility to the most cost-effective prices. Caremark Cost Saver is primarily geared towards offering competitive prices for commonly prescribed non-specialty generic medications.

Pharmacy 96

Pharmacy Drugs Clinical Trials Clinical Trials 96

XTalks

APRIL 18, 2024

However, Roche has several CSF tests on the market, which include assays in the company’s Elecsys line that are used in conjunction with PET in the diagnosis and monitoring of the disease. There are currently no FDA-authorized blood tests for detecting Alzheimer’s disease.

Clinical Trials 52

Clinical Trials Clinical Trials In-Vitro Protein 52

pharmaphorum

JANUARY 31, 2022

It is becoming increasingly important for people all over the world to understand the importance of vaccines and to have access to the vaccines they need – especially with digital innovation driving new vaccine development. Pfizer’s Josh Raysman, Saad Saeed, and Shanaya Deboo discuss vaccine awareness, access, and innovation.

Vaccination 97

Vaccination Vaccine Development Marketing 97

Camargo

MAY 10, 2021

Each month, Camargo’s “In the News” series highlights important changes and advancements in the regulatory and development space and explores how those changes could impact your program. In the News: April 2021 Regulatory and Development Updates. In the News: March 2021 Regulatory and Development Updates.

Development 185

Development Clinical Trials Clinical Trials Trials 185

pharmaphorum

JANUARY 20, 2022

This news will likely be welcomed by sufferers, as, currently, there is no cure for UC. Galapagos, based in Belgium, is responsible for the commercialisation of the product in Europe, while Gilead holds the rights outside of Europe, including in Japan, where it is co-marketed with Eisai.

Drugs 98

Drugs Medicine Production Development 98

Sciensano

NOVEMBER 28, 2023

Enhance self-management support, and labour market participation for individuals diagnosed with CVD and diabetes. Improve data availability, quality, and accessibility across the patient journey. Implement effective primary prevention measures, screening and improved care pathways for CVD and diabetes among high-risk groups.

Development 98

Development Marketing Research 98

XTalks

JANUARY 9, 2023

Roche noted that the drug is an accessible, off-the-shelf treatment option. Its greater accessibility gives it an edge over the gene therapies, which are more complex and expensive to develop and can lead to patients often waiting several weeks for an infusion.

FDA Approval 98

FDA Approval Gene Therapy Antibody Gene 98

pharmaphorum

NOVEMBER 18, 2020

The decision means that with two CGRP antibodies now cleared for migraine prevention, the first drug in the class to be approved in Europe – Novartis’ Aimovig (erenumab) – has fallen further behind its rivals in getting access to the UK market.

Sales 96

Sales Botox Antibody Drugs 96

pharmaphorum

NOVEMBER 18, 2020

The decision means that with two CGRP antibodies now cleared for migraine prevention, the first drug in the class to be approved in Europe – Novartis’ Aimovig (erenumab) – has fallen further behind its rivals in getting access to the UK market.

Sales 94

Sales Botox Antibody Drugs 94

Drug Discovery World

FEBRUARY 1, 2023

Michael Sassano , CEO at SOMAÍ Pharmaceuticals looks at what’s needed throughout Europe to help increase access to medicinal cannabis and the current state of pharmaceutical research in this area. But for this market to become a reality, we need much more research into cannabis products and potential indications.

Clinical Trials 52

Clinical Trials Clinical Trials Medicine Trials 52

pharmaphorum

SEPTEMBER 30, 2022

” (1/2) BREAKING NEWS: @US_FDA approved AMX0035, a new treatment that has been shown to slow progression of #ALS and extend life. ” In both the US and Canada, staying on the market will depend on the outcome of the 600-patient PHOENIX study in two years. . Bad news for Biohaven. pic.twitter.com/Kck0tp1nSJ.

Drugs 98

Drugs Doctors Doctor FDA Approval 98

Drug Discovery World

JULY 15, 2022

News round-up by DDW’s Reece Armstrong for 11 – 15 July. Urgent access to vaccines that can fight and prevent infections, and curb the risk of antimicrobial resistance (AMR) is needed to save lives, according to a report by the World Health Organisation (WHO). Urgency a must for global fight against AMR, report says.

Life Science 52

Life Science Drugs Vaccination Vaccine 52

pharmaphorum

JULY 11, 2022

“Improving access to new therapies is crucial to enable clinicians to select the most appropriate therapy for each individual patient, so this is welcomed news for those living with PsA,” she said. The post NICE makes J&J’s Tremfya more accessible in England and Wales appeared first on.

Drugs 52

Drugs Sales Marketing 52

WCG Clinical

APRIL 3, 2023

Each business day, the new FDAnews will deliver precisely what pharmaceutical and medical device manufacturers have told us they need to know about regulatory compliance and good manufacturing practices,” said Terri Moench, RPh, MS, President, Research Solutions for WCG.

Compliance 52

Compliance Drugs Manufacturing Regulation 52

The Pharma Data

DECEMBER 29, 2020

FDA Authorizes Marketing of EndoRotor System. Food and Drug Administration granted marketing authorization to the EndoRotor System, which provides a minimally invasive way to resect and remove necrotic tissue for patients with walled-off pancreatic necrosis (WOPN), the agency announced last week. More News Resources.

Marketing 52

Marketing Trials Development Drugs 52

Drug Discovery World

OCTOBER 7, 2022

The MHRA has granted marketing authorisation for Eli Lilly’s baricitinib (Olumiant), the first licensed JAK inhibitor for the treatment of severe alopecia areata in adult patients. . The authorisation was based on BRAVE-AA1 and BRAVE-AA2 studies which both met the primary endpoint of the proportion of patients achieving SALT ?20

Licensing 52

Licensing Licensing Marketing Drugs 52

pharmaphorum

FEBRUARY 8, 2021

In the third part of this series taking stock of t he 2019 Voluntary Scheme for Branded Medicines Pricing and Access objectives, Leela Barham looks at the third VPAS objective that relates to the economy and innovation. That said, there is good news on the R&D front. Encouragement of R&D. But not by much; it went from £377.3

Life Science 105

Life Science Sales Medicine Branding 105

pharmaphorum

FEBRUARY 24, 2022

Following a period of restricted access, the once-a-day capsule will now be recommended for routine use in the NHS. . Initially, NICE cleared niraparib to be made available through the Cancer Drugs Fund (CDF) – a programme designed to increase the speed of drugs to market within spending margins – in 2021.

Regulation 52

Regulation Gene Drugs Marketing 52

Drug Discovery World

OCTOBER 10, 2023

That this issue should feature a market report on the state of the United Kingdom’s drug discovery sector at the same time the country has regained access to Horizon Europe is somewhat of a happy coincidence. Editor Reece Armstrong provides an introduction to the Fall 2023 issue of Drug Discovery World.

Drugs 59

Drugs Scientist Research Life Science 59

XTalks

NOVEMBER 3, 2020

Nestlé recognized the growth of these services as a result of the broadening eat-at-home market and acquired meal delivery company Freshly last Friday for $950 million. Back in 2017, Nestlé purchased a 16 percent stake in Freshly to assess the growing market. Related: Just Eat Merges with GrubHub in $7.3B

Marketing 97

Marketing Packaging Packaging Sales 97

Drug Discovery World

SEPTEMBER 23, 2022

Access the DDW Fall Issue and ELRIG Drug Discovery 2022 supplement on the app? . The DDW App can be downloaded for free on Apple and Android devices to access content online and offline.??? . The role of AI and automation in personalised medicine: How can AI help in the post drug discovery process?

Drugs 52

Drugs Life Science Vaccination Vaccine 52

Intouch Solutions

AUGUST 19, 2021

For the past year and a half, we’ve been talking a lot about seriously serious issues … the ongoing pandemic , inclusive marketing , the importance of creating accessible digital content , data privacy , and more.

Branding 52

Branding Marketing 52